Revvity, Inc. (RVTY)

NYSE: RVTY · IEX Real-Time Price · USD
105.00
-0.41 (-0.39%)
Mar 28, 2024, 4:00 PM EDT - Market closed

Company Description

Revvity, Inc. provides health sciences solutions, technologies, and services in the Americas, Europe, and Asia, and internationally.

The Life Sciences segment provides instruments, reagents, informatics, software, subscriptions, detection, imaging technologies, warranties, training, and services.

Its Diagnostics segment provides instruments, reagents, assay platforms, and software products for the early detection of genetic disorders, such as pregnancy and early childhood, as well as infectious disease testing in the diagnostics market.

Its products are used for testing and screening genetic abnormalities, disorders, and diseases, including down syndrome, hypothyroidism, muscular dystrophy, infertility, and various metabolic conditions.

This segment also develops technologies that enable and support genomic workflows using protein coupled receptor and next-generation DNA sequencing for applications in oncology, immunodiagnostics, and drug discovery.

It serves pharmaceutical and biotechnology companies, laboratories, academic and research institutions, public health authorities, private healthcare organizations, doctors, and government agencies under the AutoDELFIA, BACS-on-Beads, BIOCHIPs, Bioo Scientific,BoBs , chemagic, Chitas, DELFIA, DELFIA Xpress, DOPlify, EONIS, EUROArray, EUROIMMUN, EUROLabWorkstation, EUROLINE, EUROPattern, Evolution Evoya, explorer, Fontus, Genoglyphix, GSP, Haoyuan, IDS, IDS-i10 IDS-i10T, IDS-iSYS, iLab, iQ, JANUS, LabChip, LifeCycle, LimsLink, Migele, MultiPROBE, NEXTFLEX, NextPrep, Pannoramic, Panthera Puncher, PG-Seq, PGFind PKamp, PreNAT II, Prime, Protein Clear, ProteinEXact, QSigh, QuantiVac, RONIA, Sciclone, SimplicityChrom, Specimen Gate,Superflex, Symbio, T-SPOT, Touch, Twister, Vanadis, VariSpec, ViaCord VICTOR 2D, and Zephyr brand name.

The company was formerly known as PerkinElmer, Inc. and changed its name to Revvity, Inc. in April 2023.

Revvity, Inc. was founded in 1937 and is headquartered in Waltham, Massachusetts.

Revvity, Inc.
Revvity logo
Country United States
Founded 1937
Industry Diagnostics & Research
Sector Healthcare
Employees 11,500
CEO Dr. Prahlad R. Singh Ph.D.

Contact Details

Address:
940 Winter Street
Waltham, Massachusetts 02451
United States
Phone 781-663-5791
Website perkinelmer.com

Stock Details

Ticker Symbol RVTY
Exchange NYSE
Fiscal Year January - December
Reporting Currency USD
CIK Code 0000031791
ISIN Number US7140461093
Employer ID 04-2052042
SIC Code 3826

Key Executives

Name Position
Dr. Prahlad R. Singh Ph.D. Chief Executive Officer, President and Director
Maxwell Krakowiak Senior Vice President and Chief Financial Officer
Tajinder S. Vohra Senior Vice President of Global Operations
Joel S. Goldberg Senior Vice President of Administration, General Counsel and Secretary
Miriame Victor Senior Vice President and Chief Commercial Officer
Andrew Okun Vice President, Chief Accounting Officer and Treasurer
Arvind Sundar-Rajan Vice President of Digital and Technology
Madhuri Hegde FACMG, Ph.D. Senior Vice President and Chief Scientific Officer
Jayashree Thacker Senior Vice President and Global Chief Information Officer
Stephen Barr Willoughby Senior Vice President of Investor Relations and Head of ESG

Latest SEC Filings

Date Type Title
Mar 13, 2024 ARS Filing
Mar 13, 2024 DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Mar 13, 2024 DEF 14A Other definitive proxy statements
Feb 29, 2024 144 Filing
Feb 27, 2024 144 Filing
Feb 27, 2024 10-K Annual Report
Feb 23, 2024 144 Filing
Feb 23, 2024 144 Filing
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals
Feb 14, 2024 SC 13G/A [Amend] Statement of acquisition of beneficial ownership by individuals